Background:Zinc oxide eugenol(ZOE) has long been the material of choice for obturating primary teeth,but it is resistant to resorption, might result in a deflected successor and has limited antibacterial efficacy. Curcuminpossessesanti-inflammatory and antimicrobialproperties which can be implied by its use as obturating material in primary teeth.Objective: To evaluate and compare the efficacy of Curcumin Gel mixed Endoflas powderand Zinc oxide eugenol as obturating materials in primary molars.Material and Methods: A total of 30 primary molars indicated for pulpectomy were selected from 4-9-year-old children and divided into two equal groups based on the obturating material used. Group 1- Curcumin Gel mixed Endoflas powder(CGE) and Group 2- Zinc oxide eugenol(ZOE). The efficacy of these obturation materials was evaluatedboth clinically and radiographically. Follow-up was done after 1, 3and 6months to evaluate clinical and radiographical success rates. The results were subjected to statistical analysis using SPSS software version 21 usingchi-square test.Results: At the end of the 6th month follow-up,there was 93.3% clinical success inGroup 1compared with 86.6% success in Group 2. Whereas, radiographically success reported was 100% with Group 1and93.3% with Group 2. The difference in the radiographic success rate between the two Groups was statistically significant (P <0.05).Conclusion: Based on the present study results, Curcumin Gel mixed Endoflas powder can be considered as an alternative obturation material for treating deciduous molars with extensive involvement of pulp and peri-radicular tissues.KeywordsPulpectomy;Obturating materials;Endoflas;Antimicrobials;Turmeric; Zinc oxide eugenol.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.